Learning how and why corneal scarring occurs is the key to preventing or reversing it. New discoveries from Dr. Steven E. Wilson’s laboratory might make both options feasible.
The latest in ophthalmic research, innovations, diagnostic advancements and clinical outcomes, brought to you by Cleveland Clinic’s Cole Eye Institute.
Discover how Cleveland Clinic physicians are hoping to improve survival in uveal melanoma by identifying patients with micrometastases—and suppressing them before they progress to macrometastases.
A new technique developed by Cole Eye Institute’s Elias Traboulsi, MD, has been shown to improve surgical outcomes for the roughly 5 percent of patients with thyroid eye disease who require strabismus surgery.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A $2 million grant will help Cole Eye Institute scientists produce a three-dimensional model of an individual patient’s corneal shape and material strength. The model would help identify early signs of keratoconus, and would serve as a ‘virtual eye’ to test treatments or screen refractive surgery candidates.
Good features can significantly smooth the bumpy road to the adoption of a medical records system. Customized functions can improve your work flow and practice efficiency and make the system work for you.